Established in 1997, and incorporated in 2011, Zhejiang Starry Pharmaceutical Co., Ltd. is a vertically integrated high-technology pharmaceutical manufacturer in China.
Starry Pharmaceutical is the leading API manufacuturer of X-CT non-ionic contrast medium, MRI contrast medium and Fluoroquinolones portfolio, including Iohexol, Ioversol, Iopamidol, Iodixanol, Iopromide, Iomeprol, Gadobenate Dimeglumine, Gadopentetate Dimeglumine, Gadoterate meglumine, Levofloxacin Hemihydrate, Pazufloxacin mesylate. Core product Iohexol has the COS certificate. We have the largest production scale and cover all major range of X-CT non-ionic contrast medium in China.
Starry has state-of-the-art manufacturing facilities conforming to the most stringent international GMP, our plant is, EDQM, JMDA(Japan), ISO14001 certified, and is preparing the inspection by US FDA. Perfect organziation, R&D, production, quality assurance, regulatory support, EHS, cultural, and sales mangaement system make Starry as
more >
Year of Establishment:
1997
Total Assets(USD):
Choose not to disclose
Total Number of Staff:
more than 500
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
75,000,000 to 79,999,999
Main Sales Markets:
Central/South America,Eastern Europe,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: